- Home
- MEGL vs ALBT Comparison
MEGL vs ALBT Comparison
Compare MEGL & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEGL
- ALBT
- Stock Information
- Founded
- MEGL 2016
- ALBT 2014
- Country
- MEGL Hong Kong
- ALBT United States
- Employees
- MEGL N/A
- ALBT N/A
- Industry
- MEGL Finance: Consumer Services
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MEGL Finance
- ALBT Health Care
- Exchange
- MEGL Nasdaq
- ALBT Nasdaq
- Market Cap
- MEGL 6.8M
- ALBT 7.4M
- IPO Year
- MEGL 2022
- ALBT N/A
- Fundamental
- Price
- MEGL $1.33
- ALBT $2.33
- Analyst Decision
- MEGL
- ALBT
- Analyst Count
- MEGL 0
- ALBT 0
- Target Price
- MEGL N/A
- ALBT N/A
- AVG Volume (30 Days)
- MEGL 27.8K
- ALBT 64.7K
- Earning Date
- MEGL 10-29-2025
- ALBT 08-14-2025
- Dividend Yield
- MEGL N/A
- ALBT N/A
- EPS Growth
- MEGL N/A
- ALBT N/A
- EPS
- MEGL N/A
- ALBT N/A
- Revenue
- MEGL $1,645,862.00
- ALBT $1,159,091.00
- Revenue This Year
- MEGL N/A
- ALBT N/A
- Revenue Next Year
- MEGL N/A
- ALBT N/A
- P/E Ratio
- MEGL N/A
- ALBT N/A
- Revenue Growth
- MEGL N/A
- ALBT N/A
- 52 Week Low
- MEGL $1.02
- ALBT $1.87
- 52 Week High
- MEGL $5.52
- ALBT $11.66
- Technical
- Relative Strength Index (RSI)
- MEGL 39.06
- ALBT 54.34
- Support Level
- MEGL $1.34
- ALBT $2.04
- Resistance Level
- MEGL $1.50
- ALBT $2.19
- Average True Range (ATR)
- MEGL 0.06
- ALBT 0.14
- MACD
- MEGL -0.00
- ALBT 0.04
- Stochastic Oscillator
- MEGL 15.00
- ALBT 95.48
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.